SI9720063A - Postopek za proizvodnjo IgM preparata za intravenozno aplikacijo - Google Patents

Postopek za proizvodnjo IgM preparata za intravenozno aplikacijo Download PDF

Info

Publication number
SI9720063A
SI9720063A SI9720063A SI9720063A SI9720063A SI 9720063 A SI9720063 A SI 9720063A SI 9720063 A SI9720063 A SI 9720063A SI 9720063 A SI9720063 A SI 9720063A SI 9720063 A SI9720063 A SI 9720063A
Authority
SI
Slovenia
Prior art keywords
igm
protein
protease
suspension
aqueous solution
Prior art date
Application number
SI9720063A
Other languages
English (en)
Slovenian (sl)
Inventor
Markus Rentsch
Original Assignee
Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk filed Critical Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk
Publication of SI9720063A publication Critical patent/SI9720063A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SI9720063A 1996-10-14 1997-10-14 Postopek za proizvodnjo IgM preparata za intravenozno aplikacijo SI9720063A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810690A EP0835880A1 (de) 1996-10-14 1996-10-14 Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
PCT/CH1997/000388 WO1998016558A1 (de) 1996-10-14 1997-10-14 VERFAHREN ZUR HERSTELLUNG EINES IgM-PRÄPARATES FÜR DIE INTRAVENÖSE APPLIKATION

Publications (1)

Publication Number Publication Date
SI9720063A true SI9720063A (sl) 1999-08-31

Family

ID=8225725

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9720063A SI9720063A (sl) 1996-10-14 1997-10-14 Postopek za proizvodnjo IgM preparata za intravenozno aplikacijo

Country Status (19)

Country Link
US (1) US6136312A (ru)
EP (1) EP0835880A1 (ru)
JP (1) JP2001504092A (ru)
KR (1) KR20000048826A (ru)
CN (1) CN1233258A (ru)
AU (1) AU725134B2 (ru)
BR (1) BR9712306A (ru)
CA (1) CA2266848A1 (ru)
CZ (1) CZ125599A3 (ru)
HU (1) HUP0001069A3 (ru)
ID (1) ID21364A (ru)
IL (1) IL129383A0 (ru)
NO (1) NO991733L (ru)
NZ (1) NZ334885A (ru)
PL (1) PL332774A1 (ru)
RU (1) RU2191032C2 (ru)
SI (1) SI9720063A (ru)
SK (1) SK46699A3 (ru)
WO (1) WO1998016558A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
TW200510532A (en) * 2003-07-15 2005-03-16 Chugai Pharmaceutical Co Ltd IgM production by transformed cell and method of quantifying the same
US7803914B2 (en) * 2003-10-09 2010-09-28 Chugai Seiyaku Kabushiki Kaisha Methods for stabilizing protein solutions
JP4762717B2 (ja) * 2003-10-09 2011-08-31 中外製薬株式会社 ＩｇＭ高濃度安定化溶液
JP5697847B2 (ja) * 2006-01-30 2015-04-08 グリフオルス・セラピユーテイクス・インコーポレーテツドＧｒｉｆｏｌｓ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ＩｇＭを使用する治療方法および予防方法
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
CN102089005A (zh) * 2008-05-12 2011-06-08 斯特罗克斯生物制药有限责任公司 金黄色葡萄球菌特异性抗体制剂
CN101721633B (zh) * 2008-10-16 2011-12-21 岳道友 一种促进动物生长的中草药
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
WO2015187779A1 (en) 2014-06-03 2015-12-10 Xbiotech, Inc. Compositions and methods for treating and preventing staphylococcus aureus infections
AR122931A1 (es) * 2020-07-10 2022-10-19 Grifols Worldwide Operations Ltd Procedimiento para obtener una composición que comprende inmunoglobulina m derivada de plasma humano

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
DE3927112C1 (ru) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
AU4449597A (en) 1998-05-11
AU725134B2 (en) 2000-10-05
US6136312A (en) 2000-10-24
HUP0001069A3 (en) 2000-12-28
NZ334885A (en) 2000-09-29
NO991733L (no) 1999-06-11
NO991733D0 (no) 1999-04-13
BR9712306A (pt) 1999-08-31
JP2001504092A (ja) 2001-03-27
EP0835880A1 (de) 1998-04-15
ID21364A (id) 1999-05-27
RU2191032C2 (ru) 2002-10-20
IL129383A0 (en) 2000-02-17
SK46699A3 (en) 2000-06-12
WO1998016558A1 (de) 1998-04-23
CZ125599A3 (cs) 1999-07-14
KR20000048826A (ko) 2000-07-25
PL332774A1 (en) 1999-10-11
CN1233258A (zh) 1999-10-27
CA2266848A1 (en) 1998-04-23
HUP0001069A2 (hu) 2000-10-28

Similar Documents

Publication Publication Date Title
Waldmann et al. Metabolism of immunoglobulins
US5886154A (en) Chromatographic method for high yield purification and viral inactivation of antibodies
EP2272870B1 (en) Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products
DE68903558T2 (de) Verfahren zur inaktivierung von viren.
DE3825429C2 (de) Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927111C3 (de) Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
EP0447585B1 (de) Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates
SI9720063A (sl) Postopek za proizvodnjo IgM preparata za intravenozno aplikacijo
US4318902A (en) Concentrated immunoglobulin solution suited for intravenous administration
KR960006939A (ko) 분배제로서 카프릴산 나트륨을 사용하는 저온 알부민 분별법
EP0085747B2 (de) Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
EP0853944B1 (de) Präparation umfassend Thiolgruppen-haltige Proteine
CA1216792A (en) Method of inactivating incompatibility-reaction- causing substances
CA2161682A1 (en) Liquid globulin composition for intravenous injection, process for producing the same, and method of inhibiting globulin dimer increase in said composition
DE2311333C2 (de) Verfahren zur Herstellung eines intravenös injizierbaren modifizierten Immunserumglobulins
SK165899A3 (sk) Príprava ľudského imunoglobulínu s histamfnom